Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 15.532\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. COC(=O)c1ccc(NC(=O)C[n+]2ccccc2)cc1.[Cl-]
b. CN1C(=O)/C(=C/c2ccc(OCc3cccc(F)c3)cc2)NC1=S
Answer: b. CN1C(=O)/C(=C/c2ccc(OCc3cccc(F)c3)cc2)NC1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1C(=O)/C(=C/c2ccc(OCc3cccc(F)c3)cc2)NC1=S
CN1C(=O)/C(=C/c2ccc(OCc3cccc(F)c3)cc2)NC1=S
(5Z)-5-[[4-[(3-fluorophenyl)methoxy]phenyl]methylidene]-3-methyl-2-sulfanylideneimidazolidin-4-one